within Pharmacolibrary.Drugs.ATC.N;

model N04AA11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.35,
    Cl             = 0.00035,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N04AA11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Bornaprine is a synthetic anticholinergic agent, classified as a muscarinic antagonist. It is used in the management of Parkinson's disease and for the treatment of extrapyramidal disorders. Bornaprine was previously marketed in some European countries, but is generally not widely used or approved in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult subjects based on chemical similarity to related anticholinergic agents (e.g. trihexyphenidyl, biperiden). No direct human pharmacokinetic studies for bornaprine could be identified in the literature.</p><h4>References</h4><ol><li><p>Neidlein, R, et al., &amp; Weymann, J (1989). [The disposition of bornaprine hydrochloride in the rat. 1. Pharmacokinetics: synthesis, plasma level and elimination]. <i>Arzneimittel-Forschung</i> 39(4) 484–487. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2751734/\">https://pubmed.ncbi.nlm.nih.gov/2751734</a></p></li><li><p>Mayo, BC, et al., &amp; O&#x27;Kelly, DA (1980). The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 10(12) 873–888. DOI:<a href=\"https://doi.org/10.3109/00498258009033821\">10.3109/00498258009033821</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7210700/\">https://pubmed.ncbi.nlm.nih.gov/7210700</a></p></li><li><p>Neidlein, R, et al., &amp; Weymann, J (1989). [The disposition of bornaprine hydrochloride in the rat. 2. The metabolism of exo-epimers]. <i>Arzneimittel-Forschung</i> 39(5) 564–569. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2757672/\">https://pubmed.ncbi.nlm.nih.gov/2757672</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N04AA11;
